6 Results for "

LY 333531

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "LY 333531" in MCE Product Catalog:

  • Targets Recommended:
14
14 Publications Verification
Referencia número: HY-10195
No. CAS: 169939-94-0
Pureza:  99.48%
Synonyms: LY333531
Target:  

PKC

Áreas de investigación:  

Metabolic Disease

Ruboxistaurin (LY333531) is an orally active, selective PKC beta inhibitor (Ki=2 nM). Ruboxistaurin exhibits ATP dependent competitive inhibition of PKC beta I with an IC50 of 4.7 nM. Ruboxistaurin inhibits PKC beta II with an IC50 of 5.9 nM .
loading...
    loading...
14
14 Publications Verification
Referencia número: HY-10195B
No. CAS: 169939-93-9
Pureza:  99.94%
Synonyms: LY333531 hydrochloride
Target:  

PKC

Áreas de investigación:  

Metabolic Disease

Ruboxistaurin (LY333531) hydrochloride is an orally active, selective PKC beta inhibitor (Ki=2 nM). Ruboxistaurin hydrochloride exhibits ATP dependent competitive inhibition of PKC beta I with an IC50 of 4.7 nM. Ruboxistaurin hydrochloride inhibits PKC beta II with an IC50 of 5.9 nM .
loading...
    loading...
14
14 Publications Verification
Referencia número: HY-10195A
No. CAS: 192050-59-2
Pureza:  99.87%
Synonyms: LY333531 mesylate
Target:  

PKC

Áreas de investigación:  

Cardiovascular Disease Metabolic Disease

Ruboxistaurin (LY333531) mesylate is an orally active, selective and ATP competitive PKCβ inhibitor with IC50 values of 4.7 and 5.9 nM for PKCβI and PKCβII, respectively. Ruboxistaurin mesylate can be used for the research of eye disorders, heart failure and diabetes .
loading...
    loading...
Referencia número: HY-10195R
No. CAS: 169939-94-0
Synonyms: LY333531 (Standard)
Target:  

Reference Standards PKC

Áreas de investigación:  

Metabolic Disease

Ruboxistaurin (Standard) is the analytical standard of Ruboxistaurin. This product is intended for research and analytical applications. Ruboxistaurin (LY333531) is an orally active, selective PKC beta inhibitor (Ki=2 nM). Ruboxistaurin exhibits ATP dependent competitive inhibition of PKC beta I with an IC50 of 4.7 nM. Ruboxistaurin inhibits PKC beta II with an IC50 of 5.9 nM .
loading...
    loading...
Referencia número: HY-10195BS
No. CAS: 1794767-04-6
Ruboxistaurin-d6 (hydrochloride) is the deuterium labeled Ruboxistaurin hydrochloride. Ruboxistaurin (LY333531) hydrochloride is an orally active, selective PKC beta inhibitor (Ki=2 nM). Ruboxistaurin hydrochloride exhibits ATP dependent competitive inhibition of PKC beta I with an IC50 of 4.7 nM. Ruboxistaurin hydrochloride inhibits PKC beta II with an IC50 of 5.9 nM .
loading...
    loading...
Referencia número: HY-10195BR
No. CAS: 169939-93-9
Synonyms: LY333531 hydrochloride (Standard)
Target:  

Reference Standards PKC

Áreas de investigación:  

Metabolic Disease

Ruboxistaurin hydrochloride (Standard) is the analytical standard of Ruboxistaurin hydrochloride (HY-10195B). This product is intended for research and analytical applications. Ruboxistaurin (LY333531) hydrochloride is an orally active, selective PKC beta inhibitor (Ki=2 nM). Ruboxistaurin hydrochloride exhibits ATP dependent competitive inhibition of PKC beta I with an IC50 of 4.7 nM. Ruboxistaurin hydrochloride inhibits PKC beta II with an IC50 of 5.9 nM .
loading...
    loading...